Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapy

OBJECTIVES: Strategies to improve the responsiveness of programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1) checkpoint blockade therapy remain an essential topic in cancer immunotherapy. In this study, we developed a new radiolabeled nanobody-based imaging probe (99m)Tc-MY1523 targeting PD-L...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Hannan, Wu, Yue, Shi, Jiyun, Zhang, Xin, Liu, Tianyu, Hu, Biao, Jia, Bing, Wan, Yakun, Liu, Zhaofei, Wang, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674096/
https://www.ncbi.nlm.nih.gov/pubmed/33203663
http://dx.doi.org/10.1136/jitc-2020-001156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674096/
https://www.ncbi.nlm.nih.gov/pubmed/33203663
http://dx.doi.org/10.1136/jitc-2020-001156

Ejemplares similares